{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:51:13Z","timestamp":1794649873099,"version":"4.9.1"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:00:00Z","timestamp":1124409600000},"content-version":"vor","delay-in-days":810,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2003,6]]},"abstract":"<jats:p>Expression and gain\u2010of\u2010function mutation of the <jats:italic>c\u2010kit<\/jats:italic> gene, that encodes a receptor tyrosine kinase (KIT), have been reported in mast cell tumors and gastrointestinal stromal tumors (GISTs). Among human testicular germ cell tumors (GCTs), seminomas and seminoma components of mixed GCTs have also been shown to express KIT, but only one study has found the <jats:italic>c\u2010kit<\/jats:italic> gene mutation at exon 17 in seminoma. To elucidate the frequency and location of the <jats:italic>c\u2010kit<\/jats:italic> gene mutation of testicular GCTs, we analyzed the whole coding region of the <jats:italic>c\u2010kit<\/jats:italic> complementary DNA along with 4 mutational hot spots (exons 9, 11, 13 and 17) of the <jats:italic>c\u2010kit<\/jats:italic> genomic DNA by polymerase chain reaction and direct sequencing. Somatic mutations were found in 4 pure seminomas of 34 testicular GCTs (11.8%). One mutation was found in exon 11 (W557R) and the others were observed in exon 17 (D816H and D816V). These types of mutations were reported in GISTs (W557R), seminoma (D816H) and mastocytosis (D816V) and were considered to be gain\u2010of\u2010function mutations, although there were no differences of any clinicopathological factors or outcome between patients with and without mutations. Additionally, we also demonstrated coexpression of Gly\u2010Asn\u2010Asn\u2010Lys<jats:sup>510\u2013513<\/jats:sup> (GNNK)+ and GNNK\u2010 isoforms of the <jats:italic>c\u2010kit<\/jats:italic> gene with dominance of the GNNK\u2010 transcript in all testicular GCTs. The mutations and\/or preferential expression of GNNK\u2010 isoform of the <jats:italic>c\u2010kit gene<\/jats:italic> might play an important role in the development of testicular GCTs, and these tumors may also be targets for STI571, which is a promising drug for advanced and metastatic GISTs.<\/jats:p>","DOI":"10.1111\/j.1349-7006.2003.tb01470.x","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T10:19:55Z","timestamp":1124446795000},"page":"486-491","source":"Crossref","is-referenced-by-count":91,"title":["Alterations of the <i>c\u2010kit<\/i> gene in testicular germ cell tumors"],"prefix":"10.1111","volume":"94","author":[{"given":"Yuji","family":"Sakuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Oguni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsugu","family":"Hironaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Salto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"e_1_2_1_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00117-8"},{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(99)00076-X"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343784"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116761"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1609"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.577"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64946-2"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64795-5"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33024"},{"key":"e_1_2_1_11_2","first-page":"8118","article-title":"KIT activation is a ubiquitous feature of gastrointestinal stromal tumors","volume":"61","author":"Rubin BP","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65419-3"},{"key":"e_1_2_1_13_2","first-page":"2416","article-title":"Preferential expression of c\u2010kit protooncogene transcripts in small cell lung cancer","volume":"51","author":"Sekido Y","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64850-X"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2001.tb01121.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1999.tb00715.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020461"},{"key":"e_1_2_1_18_2","first-page":"1115","article-title":"Juxtamembrane mutant V560GKH is more sensitive to Imatinib (STI571) compared with wild\u2010type c\u2010kit whereas the kinase domain mutant D816VKH is resistant","volume":"1","author":"Frost MJ","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1741"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711770307"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01261407"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199502000-00073"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000032410.46986.7B"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.7.3347"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200002000-00045"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02911.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1991.tb07784.x"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202939"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.1.297"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0350"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2003.tb01470.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2003.tb01470.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T14:56:46Z","timestamp":1700233006000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2003.tb01470.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["10.1111\/j.1349-7006.2003.tb01470.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2003.tb01470.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}